• Reverba Co-Founder and CEO Cheryl Lubbert named Women Leaders in Business Gold Globee® Winner
    Reverba Co-Founder and CEO Cheryl Lubbert named Women Leaders in Business Gold Globee® Winner

    – Awards recognize individuals and women-led organizations who have demonstrated extraordinary dedication and innovation – SEATTLE – October 18, 2023 – Reverba, a leading global patient engagement company, today announced…

  • Authenticity In An Automated World: Surprising Guidance From Healthcare
    Authenticity In An Automated World: Surprising Guidance From Healthcare

    Published in Forbes By: Cheryl Lubbert, Forbes Councils Member When faced with online customer service “agents” who don’t have real answers or solutions for specific problems, email responses that don’t…

  • Embrace the Rainbow: Three Tips to Make DEI Foundational In Your Clinical Program
    Embrace the Rainbow: Three Tips to Make DEI Foundational In Your Clinical Program

    By: Jean McCoy Diversity in clinical trials is a hot-button topic, with attention and programs ranging from legislation (both proposed and passed) to industry conference panels and required continuing education…

  • Our Commitment to Patient Data Security and Privacy: Ongoing SOC 2®, Type II Certification
    Our Commitment to Patient Data Security and Privacy: Ongoing SOC 2®, Type II Certification

    SOC 2 certification aligns Reverba with world-class organizations achieving the highest level of security and compliance for data management for service organizations – SEATTLE – April 20, 2023 – Reverba,…

  • The Patient Voice: Industry and Advocates Speak in Harmony
    The Patient Voice: Industry and Advocates Speak in Harmony

    By: Jean McCoy A generation ago, HIV/AIDS patients had to “Act Up” to be heard. A recent virtual summit shows how much has changed since the days of that pioneering…

  • How Can We Have More Successful Rare Disease Trials?
    How Can We Have More Successful Rare Disease Trials?

    By: Reverba Clinical Partnerships Team More than 300 million people around the world live with a rare disease—that is, a condition that affects fewer than 1 in 2,000. Although each…

  • Patient insights on trials: improving trust, the experience, and diversity.
    Patient insights on trials: improving trust, the experience, and diversity.

    By: Reverba Clinical Partnerships Team We have all made New Year’s resolutions – some we keep, and some never come to fruition. What are your goals as an organization? You…

  • Patient Engagement: What Matters Most in 2023. A retrospective by Cheryl Lubbert
    Patient Engagement: What Matters Most in 2023. A retrospective by Cheryl Lubbert

    By: Cheryl Lubbert Think about 2022 – what stands out to you the most? For me, it’s how often we heard that things were “returning to normal” after two years…

  • Reverba Celebrates 20 Years of Amplifying Patient Voices
    Reverba Celebrates 20 Years of Amplifying Patient Voices

    – 20th Anniversary demonstrates Reverba has the staying power and adaptability to continue leading the way in patient engagement solutions for life sciences companies – SEATTLE – October 10, 2022…

  • It’s Our Anniversary: 20 Years, 20 Reasons to Believe
    It’s Our Anniversary: 20 Years, 20 Reasons to Believe

    By: Cheryl Lubbert Today, we turn 20. Sixteen may be sweet, but twenty means so much more when you’re talking about the lifetime of a company. In an age of…

  • HBA Rising Star: Stephanie Hayes
    HBA Rising Star: Stephanie Hayes

    By: Cheryl Lubbert As a pioneer in patient engagement, Reverba wouldn’t be where it is today without a talented team of individuals in roles spanning the organization. Every so often,…

  • Health Perspectives Group becomes Reverba
    Health Perspectives Group becomes Reverba

    Entering the company’s 20th year, this new chapter represents the next level of transformativetech-enabled patient engagement for the biopharmaceutical industry – SEATTLE – November 10, 2021 – Health Perspectives Group,…